Armata Pharmaceuticals Inc (ARMP)
2.60
-0.16
(-5.80%)
USD |
NYAM |
Apr 29, 16:00
Armata Pharmaceuticals Total Liabilities (Quarterly): 130.43M for Dec. 31, 2023
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | 130.43M |
September 30, 2023 | 125.15M |
June 30, 2023 | 82.07M |
March 31, 2023 | 86.33M |
December 31, 2022 | 59.75M |
September 30, 2022 | 47.30M |
June 30, 2022 | 47.69M |
March 31, 2022 | 46.23M |
December 31, 2021 | 44.37M |
September 30, 2021 | 18.92M |
June 30, 2021 | 19.66M |
March 31, 2021 | 18.83M |
December 31, 2020 | 20.66M |
September 30, 2020 | 21.06M |
June 30, 2020 | 19.82M |
March 31, 2020 | 10.62M |
December 31, 2019 | 10.86M |
September 30, 2019 | 11.17M |
June 30, 2019 | 12.29M |
March 31, 2019 | 4.656M |
December 31, 2018 | 3.413M |
September 30, 2018 | 3.766M |
June 30, 2018 | 3.381M |
March 31, 2018 | 3.109M |
December 31, 2017 | 3.407M |
Date | Value |
---|---|
September 30, 2017 | 4.024M |
June 30, 2017 | 5.245M |
March 31, 2017 | 7.654M |
December 31, 2016 | 8.43M |
September 30, 2016 | 7.808M |
June 30, 2016 | 7.795M |
March 31, 2016 | 19.36M |
December 31, 2015 | 18.78M |
September 30, 2015 | 18.42M |
June 30, 2015 | 23.28M |
March 31, 2015 | 41.68M |
December 31, 2014 | 25.18M |
September 30, 2014 | 17.08M |
June 30, 2014 | 40.28M |
March 31, 2014 | 58.46M |
December 31, 2013 | 63.84M |
September 30, 2009 | 1.797M |
June 30, 2009 | 2.099M |
March 31, 2009 | 10.88M |
December 31, 2008 | 10.92M |
September 30, 2008 | 12.24M |
June 30, 2008 | 13.25M |
March 31, 2008 | 11.23M |
December 31, 2007 | 12.23M |
September 30, 2007 | 10.64M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
10.62M
Minimum
Mar 2020
130.43M
Maximum
Dec 2023
43.85M
Average
21.06M
Median
Sep 2020
Total Liabilities (Quarterly) Benchmarks
AIM ImmunoTech Inc | 9.147M |
Perspective Therapeutics Inc | 22.71M |
Protalix BioTherapeutics Inc | 50.86M |
Electromed Inc | 6.622M |
Xtant Medical Holdings Inc | 41.26M |
Total Liabilities (Quarterly) Related Metrics
Total Assets (Quarterly) | 98.36M |
Shareholders Equity (Quarterly) | -32.06M |